Skip to main content
Premium Trial:

Request an Annual Quote

Korean Biotechnology Company Sequences Genome of Korean Man

NEW YORK, June 27 - Macrogen, a Korean biotechnology company, has sequenced its own draft of the human genome using the DNA of a 22 year-old Korean man, The Korea Times reported Wednesday.

After sequencing the DNA, Macrogen compared the 96,768 BAC clones that the company collected with Celera's version of the human genome, published last February in Science . Macrogen officials claimed to have found specific genes unique to the Korean population.

Macrogen began its sequencing efforts in 1999, to develop a genomic database specific to Koreans that the company could use as a basis for designing DNA chips and developing personalized genetic diagnostics. The newspaper reported that the company is searching for markers for diseases such as cancer of the lung, colon, pancreas, and breast.

Founded in 1997, the company has provided transgenic mouse services for biomedical researchers, and more recently began developing a biochip arrayed with cDNA clones, for cancer diagnosis, according to the company website. The company is also interested in finding SNPs specific to the Korean population.

"Considering that we are planning to make the DNA Chip for diagnostic purposes within two years, it is very important to have a Korean gene pool since the genetic background of Koreans is thought to be quite different from that of the American/European gene pool," the company said on its website. "We expect that our DNA chip can also be used in Asia including Japan and China."

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.